GE HealthCare (GEHC) announced advancements in research tools and MR systems that aim to accelerate discovery, strengthen collaboration across research programs, and turn innovation into meaningful clinical achievements. GE HealthCare continues to invest in advanced MR technology with its next-generation SIGNAT MR systems and research tools designed to help academic and clinical research programs move faster, work more collaboratively, and push the boundaries of discovery. By combining high-performance hardware with advanced software and deep learning-based techniques, these innovations are intended to reduce scanning and examination times, improve image quality, and enable more consistent data across sites and studies. “Our focus at ISMRM 2026 is to enable the research ecosystem that helps researchers explore new questions, scale collaboration and translate discoveries more efficiently to broaden clinical impact,” said Kelly Londy, President & CEO, MR and Women’s Health at GE HealthCare. “From high-performance systems to collaboration resources for productive MR research, we are committed to giving researchers the tools they need to work together more effectively, explore new frontiers, and accelerate the path from discovery to patient experience.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Butterfly, GE Healthcare, Blue Owl, MSCI, International Paper Insider Shake-Up
- GE HealthCare price target lowered to $85 from $89 at Oppenheimer
- GE HealthCare price target lowered to $80 from $85 at Evercore ISI
- GE HealthCare price target lowered to $65 from $80 at JPMorgan
- Meta downgraded, Qualcomm upgraded: Wall Street’s top analyst calls
